Kangtuo Medical (688314.SH) disclosed its 2024 annual report, reporting revenue of 322 million yuan for the reporting period, a year-on-year increase of 17.06%; net profit attributable to shareholders of 88.84 million yuan, a year-on-year increase of 17.07%; net profit after deducting non-recurring gains and losses of 74.86 million yuan, a year-on-year increase of 9.52%; basic earnings per share of 1.09 yuan. The company proposes to distribute a cash dividend of 1.8 yuan (including tax) for every 10 shares to all shareholders.

In the field of neurosurgery, core products have performed well. The combined revenue from PEEK materials and titanium materials reached 278.0188 million yuan, a year-on-year increase of 14.09%, accounting for 89.19% of main business revenue. Among them, PEEK material products achieved a revenue of 205.8373 million yuan, a year-on-year increase of 23.33%, with the proportion of main business revenue rising by 2.48 percentage points to 66.03%; titanium material products achieved a revenue of 72.1814 million yuan, accounting for 23.16% of main business revenue, a decrease of 6.08 percentage points compared to the same period last year.

The company seizes the opportunities presented by regional centralized procurement policies and accelerates the clinical replacement of traditional titanium materials with PEEK material products. It has successfully launched the "4D Bioactive Plate" and a full PEEK material cranial repair solution. During the reporting period, the company continuously optimized its products through technological innovation, enhancing the postoperative experience for patients and consolidating its leading position in the field of neurosurgical repair and fixation.

Xi'an Kangtuo Medical Technology Co., Ltd. was established in 2005 and focuses on specialized fields such as neurosurgery, cardiovascular surgery, craniofacial surgery, and dentistry. It is a high-tech enterprise that integrates the research and development, production, and sales services of Class III implantable medical devices.

Since its establishment, Xi'an Kangtuo has rooted itself in the research, processing, and production of medical titanium metals and polymer materials. It has currently obtained more than a dozen patents for implantable medical devices and multiple product registration certificates. The R&D and production base of Xi'an Kangtuo is located in Xi'an, and it is equipped with TORNOS high-precision CNC machine tools, Sodick wire-cut electric discharge machining machines, multi-axis linkage vertical machining centers, and a class 10000 cleanroom.